Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. (Q30362783)

20 June 2017

title

Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. (English)

1 reference

20 June 2017

0 references

1 reference

4

0 references

Ilkka Julkunen

Ilkka Julkunen

5

0 references

Birgitte Rahbek Kornum

Birgitte Rahbek Kornum

2

0 references

Markku Partinen

Markku Partinen

1

0 references

Giuseppe Plazzi

Giuseppe Plazzi

3

0 references

author name string

Outi Vaarala

6

1 reference

20 June 2017

publication date

1 June 2014

1 reference

20 June 2017

1 reference

20 June 2017

volume

13

1 reference

20 June 2017

issue

6

1 reference

20 June 2017

page(s)

600-613

1 reference

Sleep Disorders Classification Committee, Association of Sleep Disorders Centers

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

How age influences the expression of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Reduced number of hypocretin neurons in human narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Isolated motor phenomena and symptoms of sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy as an adverse event following immunization: case definition and guidelines for data collection, analysis and presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

A community survey of neurological disorders in Saudi Arabia: the Thugbah study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Hypnagogic and hypnopompic hallucinations: pathological phenomena?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The prevalence of narcolepsy among Chinese in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Prevalence of narcolepsy symptomatology and diagnosis in the European general population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Prevalence of narcolepsy-cataplexy in Korean adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Prevalence of narcolepsy with cataplexy in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Autosomal dominant cerebellar ataxia deafness and narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy and cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The clinical features of cataplexy: A questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Nocturnal aspects of narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Periodic leg movements during sleep in narcoleptic patients with or without restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Childhood narcolepsy in North China.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Clinical features of childhood narcolepsy. Can cataplexy be foretold?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Complex movement disorders at disease onset in childhood narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Clinical and polysomnographic course of childhood narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Socio-professional handicap and accidental risk in patients with hypersomnias of central origin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naïve patients and the general Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Psychosocial and intellectual functioning in childhood narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The socioeconomic impact of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The burden of narcolepsy with cataplexy: how disease history and clinical features influence socio-economic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Variant between CPT1B and CHKB associated with susceptibility to narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy is strongly associated with the T-cell receptor alpha locus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Common variants in P2RY11 are associated with narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Immune cell regulation by autocrine purinergic signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

ImmunoChip study implicates antigen presentation to T cells in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Occurrence of sleep disorders in the families of narcoleptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Familial aggregation of narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Concomitant loss of dynorphin, NARP, and orexin in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy: neural mechanisms of sleepiness and cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Hypothalamus, hypocretins/orexin, and vigilance control

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Paradoxical (REM) sleep genesis by the brainstem is under hypothalamic control.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Melanin-concentrating hormone control of sleep-wake behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Glucose-sensing neurons of the hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Autoantibodies against alpha -MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Orexin expression is regulated by alpha-melanocyte-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Hypothalamic neuropeptides and the regulation of appetite

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Structural changes in the narcoleptic brain and their possible relevance for clinical severity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Genetic association, seasonal infections and autoimmune basis of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

A case-control study of the environmental risk factors for narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Advances in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

High-glycemic-index carbohydrate meals shorten sleep onset

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

EFNS guidelines on management of narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

A practical guide to the therapy of narcolepsy and hypersomnia syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Ephedrine-induced acute myocardial infarction in a young athlete: a case of thrombus management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

The histamine H3 receptor: from discovery to clinical trials with pitolisant

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Follow-up of four narcolepsy patients treated with intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

A remarkable effect of alemtuzumab in a patient suffering from narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Effects of hypocretin/orexin cell transplantation on narcoleptic-like sleep behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

Hypothalamic regulation of sleep and circadian rhythms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970075-4

7 January 2021

10.1016/S1474-4422(14)70075-4

Identifiers

DOI

1 reference

20 June 2017

1 reference